Cello Health BioConsulting
  • menu
  • Home
  • About us
    • Why We’re Different
    • Our Team
    • Mission, Vision & Values
  • Capabilities
    • Common Client Dilemmas
    • Opportunity Assessments
    • Opportunity Search and Evaluation
    • Portfolio and Platform Strategy
    • Business Development & Partnering Strategy
    • Market Access Strategy
    • Early Stage Strategy
  • Our Insights
    • News
    • Presentations
    • Testimonials
    • Events
  • Careers
    • Current Opportunities
    • A Day in the Life
    • Our Culture

Our Insights

Novel Cell-Type Therapeutic Platforms in Oncology: If You’ve Seen One, You’ve Seen…One

Novel Cell-Type Therapeutic Platforms in Oncology: If You’ve Seen One, You’ve Seen…One

January 26, 2021
More +
Proliferation of Novel Cell Type Platforms in the Oncology Competitive Landscape PART II (White Paper)

Proliferation of Novel Cell Type Platforms in the Oncology Competitive Landscape PART II (White Paper)

December 17, 2020
More +
Biotech and Breakthroughs in Immuno-Oncology (White Paper)

Biotech and Breakthroughs in Immuno-Oncology (White Paper)

October 13, 2020
More +
ShareVault’s Webinar: Paradigm Changing Technologies in Oncology: Catching the Next Wave of Platforms & Companies

ShareVault’s Webinar: Paradigm Changing Technologies in Oncology: Catching the Next Wave of Platforms & Companies

October 8, 2020
More +
Industry Landscape for Cell & Gene Therapy in the US and Greater Philadelphia

Industry Landscape for Cell & Gene Therapy in the US and Greater Philadelphia

September 13, 2020
More +
Futurescaping of Oncology A Technology Sampler of Potential Paradigm Changing Approaches to Treating Cancer

Futurescaping of Oncology A Technology Sampler of Potential Paradigm Changing Approaches to Treating Cancer

September 9, 2020
More +
Novel Cell-Type Therapeutic Platforms in Oncology: If You’ve Seen One, You’ve Seen…One

Novel Cell-Type Therapeutic Platforms in Oncology: If You’ve Seen One, You’ve Seen…One

August 11, 2020
More +
In Vivo Gene Therapy: Personalizing the Ultra-rare And Scaling-up for Chronic Disease

In Vivo Gene Therapy: Personalizing the Ultra-rare And Scaling-up for Chronic Disease

July 29, 2020
More +
Proliferation of Novel Cell Type Platforms in the Oncology Competitive Landscape – PART I (White Paper)

Proliferation of Novel Cell Type Platforms in the Oncology Competitive Landscape – PART I (White Paper)

July 24, 2020
More +
BIO 2020 | Future of IO Checkpoint Combinations | Available On Demand

BIO 2020 | Future of IO Checkpoint Combinations | Available On Demand

June 6, 2020
More Info +
  2. ←
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. 8
  11. 9
  12. 10
  13. →

Search

Elsewhere

Let’s work together

Contact us

  • Cello Health BioConsulting
  • 25-B Hanover Road
  • Suite 320
  • Florham Park, NJ
  • 07932
  • USA
  • +1 973 292 5001
  •  
  • Part of Cello Health plc

    Follow us

    Cello Health BioConsulting

    ©2021 Defined Health, now known as Cello Health BioConsulting | Privacy policy.

    View Presentation

    View Presentation

    Please fill the form to access the presentation.
    • This field is for validation purposes and should be left unchanged.

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in settings.

    Defined Health, now known as Cello Health BioConsulting
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

    3rd Party Cookies

    This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

    Keeping this cookie enabled helps us to improve our website.

    Please enable Strictly Necessary Cookies first so that we can save your preferences!